Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07242365

Soylent in Reducing Gastrostomy Tube Rates in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemoradiotherapy

A Phase II Study Integrating Soylent™ Meal Replacement to Reduce Gastrostomy Tube Rates in Patients With Head &Amp; Neck Cancer Undergoing Chemoradiotherapy

Status
Active Not Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Jonsson Comprehensive Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This phase II trial studies Soylent in reducing gastrostomy tube rates in patients with head and neck cancer that has spread to nearby tissues or lymph nodes (locally advanced) who are undergoing chemoradiotherapy. Soylent is a liquid meal replacement product that may reduce the risk of malnutrition and gastrostomy placement during or following treatment for head and neck cancer with chemoradiation.

Detailed description

PRIMARY OBJECTIVES: I. To determine the compliance rate of oral nutritional replacement with Soylent. II. To determine the overall therapeutic gastrostomy (G)-tube placement rate (G-tube placement from the 1st day of chemoradiation up to 4 weeks following treatment). SECONDARY OBJECTIVES: I. To determine weight loss and body mass index (BMI) changes during and following treatment. II. To determine the change in nutritional and metabolic biomarkers during treatment. III. To determine physician-reported acute and late toxicities during and following treatment. IV. To determine patient-reported quality of life during and following treatment. V. To determine clinical outcomes from treatment. OUTLINE: Patients receive Soylent orally (PO) for up to 3 months. After completion of study, patients are followed up at 1, 3, 6, 12, 16, 18 and 24 months.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSoylent Graham Dietary SupplementGiven Soylent PO
OTHERLaboratory Biomarker AnalysisCorrelative studies
OTHERQuality-of-Life AssessmentAncillary studies
OTHERQuestionnaire AdministrationAncillary studies

Timeline

Start date
2017-06-19
Primary completion
2026-12-31
Completion
2027-12-31
First posted
2025-11-21
Last updated
2026-02-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07242365. Inclusion in this directory is not an endorsement.